alexa Determination of cysteine in human plasma by high-performance liquid chromatography and ultraviolet detection after pre-column derivatization with 2-chloro-1-methylpyridinium iodide.
Pharmaceutical Sciences

Pharmaceutical Sciences

Journal of Bioequivalence & Bioavailability

Author(s): Chwatko G, Bald E

Abstract Share this page

Abstract This paper describes the development and validation of a reversed-phase HPLC method with isocratic conditions for the analysis of total cysteine in human plasma. The essential steps in the assay include derivatization of cysteine via thiol group with 2-chloro-1-methylpyridinium iodide (CMPI), separation of the formed cysteine S-pyridinium derivative from endogenous thiol derivatives, usually present in biological samples, by ion-pair reversed-phase HPLC, and ultraviolet detection. Free cystine and protein-bound cysteine are converted to their reduced counterpart by the use of 2-mercaptoethanol. The standard curve is linear over the concentration range from 20 to 300 nmol ml(-1). The recoveries are from 93.9 to 105.9\% and imprecision was at most 2.5\%. Optimal conditions are determined for all steps of the analytical procedure.
This article was published in Talanta and referenced in Journal of Bioequivalence & Bioavailability

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords